| Erin Mannion, LCSW-C | |
|
8258 Veterans Hwy Ste 13, Millersville, MD 21108-1564 | |
| (410) 768-6088 | |
| (410) 768-6444 |
| Full Name | Erin Mannion |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 13 Years |
| Location | 8258 Veterans Hwy Ste 13, Millersville, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841676277 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 17194 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Focused Solutions, Llc | 6608043849 | 12 |
News Archive
Echo Therapeutics, Inc., a medical device company focused on non-invasive continuous glucose monitoring (CGM) and associated technologies, today announced that, after numerous consultations with the Chinese government, its strategic partner, Medical Technologies Innovation Asia, Ltd., believes that Echo's locally produced needle-free CGM products will be designated as a Class 2 medical device.
Sanofi-aventis and Bristol-Myers Squibb have announced that they have reached an agreement subject to certain conditions with Apotex to settle the patent infringement lawsuit pending between the parties in the U.S. District Court for the Southern District of New York.
To expand the understanding and explanation of Alzheimer's disease, United States businessman James Truchard has given a $5 million USD gift to The University of Texas at San Antonio College of Sciences to establish the Oskar Fischer Project.
A form of artificial intelligence designed to interpret a combination of retinal images was able to successfully identify a group of patients who were known to have Alzheimer's disease, suggesting the approach could one day be used as a predictive tool, according to an interdisciplinary study from Duke University.
› Verified 4 days ago
| Entity Name | Focused Solutions, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922271634 PECOS PAC ID: 6608043849 Enrollment ID: O20120111000725 |
News Archive
Echo Therapeutics, Inc., a medical device company focused on non-invasive continuous glucose monitoring (CGM) and associated technologies, today announced that, after numerous consultations with the Chinese government, its strategic partner, Medical Technologies Innovation Asia, Ltd., believes that Echo's locally produced needle-free CGM products will be designated as a Class 2 medical device.
Sanofi-aventis and Bristol-Myers Squibb have announced that they have reached an agreement subject to certain conditions with Apotex to settle the patent infringement lawsuit pending between the parties in the U.S. District Court for the Southern District of New York.
To expand the understanding and explanation of Alzheimer's disease, United States businessman James Truchard has given a $5 million USD gift to The University of Texas at San Antonio College of Sciences to establish the Oskar Fischer Project.
A form of artificial intelligence designed to interpret a combination of retinal images was able to successfully identify a group of patients who were known to have Alzheimer's disease, suggesting the approach could one day be used as a predictive tool, according to an interdisciplinary study from Duke University.
› Verified 4 days ago
| Entity Name | Baltimore Washington Counseling Center, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780066175 PECOS PAC ID: 3779897731 Enrollment ID: O20150804005058 |
News Archive
Echo Therapeutics, Inc., a medical device company focused on non-invasive continuous glucose monitoring (CGM) and associated technologies, today announced that, after numerous consultations with the Chinese government, its strategic partner, Medical Technologies Innovation Asia, Ltd., believes that Echo's locally produced needle-free CGM products will be designated as a Class 2 medical device.
Sanofi-aventis and Bristol-Myers Squibb have announced that they have reached an agreement subject to certain conditions with Apotex to settle the patent infringement lawsuit pending between the parties in the U.S. District Court for the Southern District of New York.
To expand the understanding and explanation of Alzheimer's disease, United States businessman James Truchard has given a $5 million USD gift to The University of Texas at San Antonio College of Sciences to establish the Oskar Fischer Project.
A form of artificial intelligence designed to interpret a combination of retinal images was able to successfully identify a group of patients who were known to have Alzheimer's disease, suggesting the approach could one day be used as a predictive tool, according to an interdisciplinary study from Duke University.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Erin Mannion, LCSW-C 4458 Laplata Ave, Baltimore, MD 21211-1103 Ph: (410) 371-2953 | Erin Mannion, LCSW-C 8258 Veterans Hwy Ste 13, Millersville, MD 21108-1564 Ph: (410) 768-6088 |
News Archive
Echo Therapeutics, Inc., a medical device company focused on non-invasive continuous glucose monitoring (CGM) and associated technologies, today announced that, after numerous consultations with the Chinese government, its strategic partner, Medical Technologies Innovation Asia, Ltd., believes that Echo's locally produced needle-free CGM products will be designated as a Class 2 medical device.
Sanofi-aventis and Bristol-Myers Squibb have announced that they have reached an agreement subject to certain conditions with Apotex to settle the patent infringement lawsuit pending between the parties in the U.S. District Court for the Southern District of New York.
To expand the understanding and explanation of Alzheimer's disease, United States businessman James Truchard has given a $5 million USD gift to The University of Texas at San Antonio College of Sciences to establish the Oskar Fischer Project.
A form of artificial intelligence designed to interpret a combination of retinal images was able to successfully identify a group of patients who were known to have Alzheimer's disease, suggesting the approach could one day be used as a predictive tool, according to an interdisciplinary study from Duke University.
› Verified 4 days ago
Suzanne Matty, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 8258 Veterans Hwy, Suite 13, Millersville, MD 21108 Phone: 410-768-6088 Fax: 410-768-6444 | |
Mrs. Anna Marie Smith, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1111 Benfield Blvd Ste 104, Millersville, MD 21108 Phone: 667-600-2468 Fax: 667-600-4061 | |
Amanda Richardson, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 8258 Veterans Hwy, Suite 13, Millersville, MD 21108 Phone: 410-768-6088 Fax: 410-768-6444 | |
Alison Jones, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1114 Benfield Blvd Ste G, Millersville, MD 21108 Phone: 410-780-5203 Fax: 410-987-4301 | |
Ms. Victoria Elaine Wilson, LCSWC Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 1110 Benfield Blvd Suite H, Severna Park Professional Counseling Center, Millersville, MD 21108 Phone: 410-987-5048 Fax: 410-987-4710 | |
Erin K Oczkowski, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 8258 Veterans Hwy Ste 13, Millersville, MD 21108 Phone: 410-768-6088 Fax: 410-768-6444 | |
Summer Hecht, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 8258 Veterans Hwy, Suite 13, Millersville, MD 21108 Phone: 410-768-6088 Fax: 410-768-6444 |